<DOC>
	<DOCNO>NCT02263222</DOCNO>
	<brief_summary>This open-label dose-escalating study evaluate tolerability systemic exposure MDT-10013 men woman least 18 year age undergoing primary unilateral TKA .</brief_summary>
	<brief_title>A Feasibility Dose-escalating Study MDT-10013 Acute Postoperative Pain Following Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<criteria>1 . Is male female least 18 year age 2 . Has body mass index 18 kg/m2 40 kg/m2 3 . Is schedule undergo standard primary ( firsttime ) unilateral TKA surgery ( due osteoarthritis ) without patellar resurfacing . Standard conventional instrumentation cement component must use surgery shall conduct spinal anesthesia . 4 . Females must meet following criterion : Is nonchildbearing potential , defined woman undergone surgical sterilization 2 year postmenopausal If childbearing potential , may enrol pregnancy test result negative Screening routinely use effective method birth control low failure rate ( i.e. , hormonal contraception , intrauterine device , condom combination spermicidal cream , total sexual abstinence ) . May pregnant lactate 5 . Has read , understood , sign inform consent study entry 6 . Is mentally competent , reliable , cooperative undergo visit procedure schedule study protocol record require information . 1 . Has previous spinal surgery contraindication preclude use spinal anesthesia indicate surgery inflammatory process risk infection delay wound heal ( e.g. , autoimmune disorder ) 2 . Is schedule undergo concurrent surgical procedure ( e.g. , bilateral TKA ) 3 . Has concurrent painful condition surgery may require analgesic treatment ( nonsteroidal antiinflammatory drug [ NSAID ] opioid ) postsurgical period pain strictly relate TKA , may confound postsurgical assessment 4 . Has history allergy hypersensitivity component investigational product routine care medication 5 . Has current orthostatic hypotension ( i.e. , systolic blood pressure decrease least 20 mmHg diastolic blood pressure decrease least 10 mmHg increase heart rate 20 beat per minute within 3 minute stand ) 6 . Has clinically significant cardiovascular condition evidence physical examination , medical history , and/or baseline electrocardiogram ( ECG ) , include inadequately control hypertension 7 . Has evidence bradycardia show heart rate &lt; 50 beat per minute via screen ECG 8 . In investigator 's opinion , subject suitable candidate study treatment and/or poorly control serious medical condition , psychiatric illness , clinically significant laboratory value investigator suspect could compromise subject 's safety scientific integrity study ( e.g. , human immunodeficiency virus [ HIV ] , hepatitis B C [ hep B , hep C ] ) 9 . Has presence history local systemic malignant disease past 5 year ( history basal cell carcinoma allow ) 10 . Has undergone prior open surgery affect knee 11 . Has impair renal function ( creatinine &gt; 1.5 time upper limit normal ) 12 . Has chronic liver function impairment ( aspartate aminotransferase alanine aminotransferase &gt; 3 time upper limit normal ) 13 . Has insulindependent diabetes uncontrolled diabetes mellitus ( glycosylated hemoglobin &gt; 7 % ) 14 . Has leukopenia ( &lt; 3500 leukocytes/μL ) 15 . Has current treatment follow medication : 1 . Systemic corticosteroid within 1 month plan surgery ( intranasal/inhaled steroid acceptable ) 2 . Immunosuppressant therapy treat autoimmune disease ( e.g. , rheumatoid arthritis , multiple sclerosis , myasthenia gravis , systemic lupus erythematosus , sarcoidosis , focal segmental glomerulosclerosis , Crohn 's disease , Behcet 's disease , pemphigus , ulcerative colitis ) 3 . Oral topical product contain clonidine ( e.g. , Catapres® ) 4 . Antiepileptic drug , antipsychotic , monoamine oxidase inhibitor , lithium , sulfonamides 5 . Calcium channel blocker , digoxin , betaadrenergic blocker 16 . Chronically use opioids , define use least 20 last 30 day study Screening , unable refrain opioid use within 24 hour period surgery 17 . Investigator determine subject know suspected history drug alcohol abuse 18 . Recent dose adjustment commencement treatment selective serotonin reuptake inhibitor ( SSRIs ) , serotoninnorepinephrine reuptake inhibitor ( SNRIs ) , and/or tricyclic antidepressant ( use medication allow dose stable least 8 week receive study treatment ) 19 . Has receive investigational drug device within 30 day Screening 20 . Experiences surgical complication , investigator 's opinion , preclude implantation MDT10013 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>